Serrumab: A human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venom

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Immunotoxicology

• Publication date

  2012-05-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/1547691X.2011.649220PMID 22424317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alternative methods in toxicity testing: the current approach

  2014cited by this paper
• Scorpion Envenomation and Antivenom Therapy

  2011cited by this paper
• Therapeutic monoclonal antibodies : scFv patents as a marker of a new class of potential biopharmaceuticals

  2011cited by this paper
• Tityus serrulatus venom and toxins Ts1, Ts2 and Ts6 induce macrophage activation and production of immune mediators.

  2011cited by this paper
• Comparison of hippocampal volumes in schizophrenia, schizoaffective and bipolar disorder.

  2011cited by this paper
• A century of antivenom.

  2011cited by this paper
• Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion.

  2011cited by this paper
• A portable device for the electrical extraction of scorpion venom.

  2011cited by this paper
• In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope.

  2010cited by this paper
• Biochemical profile of dogs experimentally envenomed with Tityus serrulatus scorpion venom.

  2010influential reference
• Expression of human recombinant antibody fragments capable of partially inhibiting the phospholypase activity of Crotalus durissus terrificus venom.

  2009cited by this paper
• Tityus serrulatus scorpion venom and toxins: an overview.

  2009cited by this paper
• Available online at:

  2009cited by this paper
• Tityus serrulatus venom peptidomics: assessing venom peptide diversity.

  2008influential reference
• Evaluation of the neutralizing capacity of Androctonus crassicauda (Olivier, 1807) antivenom against Leiurus quinquestriatus (Ehrenberg, 1928) venom (Scorpiones: Buthidae)

  2008cited by this paper
• Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom.

  2006cited by this paper
• Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.

  2005cited by this paper
• Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution.

  2005cited by this paper
• Immunomodulatory Effects of the Tityus serrulatus Venom on Murine Macrophage Functions in Vitro

  2005cited by this paper
• Immunology of scorpion toxins and perspectives for generation of anti-venom vaccines.

  2005cited by this paper
• Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.

  2005cited by this paper
• Renal effects and vascular reactivity induced by Tityus serrulatus venom.

  2005influential reference
• Individual variability in Tityus serrulatus (Scorpiones, Buthidae) venom elicited by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2003influential reference
• Time course of acute-phase response induced by Tityus serrulatus venom and TsTX-I in mice.

  2003cited by this paper
• Increased plasma levels of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha in patients moderately or severely envenomed by Tityus serrulatus scorpion sting.

  2003cited by this paper
• Increased plasma levels of IL-1β, IL-6, IL-8, IL-10 and TNF-α in patients moderately or severely envenomed by Tityus serrulatus scorpion sting

  2003cited by this paper
• Report of a WHO workshop on the standardization and control of antivenoms.

  2003cited by this paper
• Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.

  2003cited by this paper
• Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins.

  2003cited by this paper
• Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes.

  2002cited by this paper
• Cardiac troponin I release after severe scorpion envenoming by Tityus serrulatus.

  2002cited by this paper
• Molecular basis for the cross-reactivity of antibodies elicited by a natural anatoxin with alpha- and beta-toxins from the venom of Tityus serrulatus scorpion.

  2002cited by this paper
• Molecular basis for the cross-reactivity of antibodies elicited by a natural anatoxin with α- and β-toxins from the venom of Tityus serrulatus scorpion

  2002cited by this paper
• Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector.

  2001cited by this paper
• Purification, amino-acid sequence and partial characterization of two toxins with anti-insect activity from the venom of the South American scorpion Tityus bahiensis (Buthidae).

  2001cited by this paper
• Recent developments on the European ban on animal experiments for cosmetics

  2001cited by this paper
• [Recent developments on the European ban on animal experiments for cosmetics].

  2001cited by this paper
• Molecular mechanisms of neurotoxin action on voltage-gated sodium channels.

  2000cited by this paper
• Scorpion toxins specific for Na+-channels.

  1999cited by this paper
• A recombinant single‐chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector

  1999cited by this paper
• Biochemical and histopathological alterations induced in rats by Tityus serrulatus scorpion venom and its major neurotoxin tityustoxin-I.

  1997influential reference
• Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases.

  1997cited by this paper
• Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology.

  1997cited by this paper
• Exploring and exploiting the antibody and Ig superfamily combining sites

  1996cited by this paper
• Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display.

  1996cited by this paper
• Isolation of toxin TsTX‐VI from Tityus serrulatus scorpion venom. Effects on the release of neurotransmitters from synaptosomes

  1996cited by this paper
• Severe scorpion envenomation in children caused by Tityus bahiensis and Tityus serrulatus

  1995cited by this paper
• Antigenic cross-reactivity among the venoms from several species of Brazilian scorpions.

  1995cited by this paper
• Production of a functional anti-scorpion hemocyanin scFv in Escherichia coli.

  1995cited by this paper
• Involvement of Fcε:RII/CD23 and L-argininedependent pathway in IgE-mediated stimulation of human monocyte functions

  1994influential reference
• Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions.

  1994cited by this paper
• Severe scorpion envenomation in Brazil. Clinical, laboratory and anatomopathological aspects.

  1994influential reference
• Scorpion sting-induced pulmonary oedema: evidence of increased alveolocapillary membrane permeability.

  1994cited by this paper
• Acute pulmonary edema after Tityus serrulatus scorpion sting in children.

  1993cited by this paper
• By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling

  1992influential reference
• Single-chain Fv proteins and their fusion proteins

  1991cited by this paper
• The antiglobulin response to therapeutic antibodies.

  1990cited by this paper
• The complete amino acid sequence of toxin TsTX-VI isolated from the venom of the scorpionTityus serrulatus

  1990cited by this paper
• PATHOPHYSIOLOGY AND TREATMENT OF SCORPION POISONING

  1989cited by this paper
• An accurate method for estimating an approximate lethal dose with few animals, tested with a Monte Carlo procedure.

  1988cited by this paper
• Improved oligonucleotide-directed mutagenesis using M13 vectors.

  1987cited by this paper
• Improved oligonucleotide site-directed mutagenesis using M13 vectors.

  1985influential reference
• Isolation and characterization of toxic proteins from the venom of the Brazilian scorpion Tityus serrulatus.

  1983cited by this paper
• A new approach to practical acute toxicity testing

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Significance of the LD50-test for the toxicological evaluation of chemical substances

  1981cited by this paper
• Purification and chemical characterization of the major toxins from the venom of the Brazilian scorpion Tityus serrulatus Lutz and Mello

  1981cited by this paper
• SIGNS, SYMPTOMS AND TREATMENT OF SEVERE SCORPION POISONING IN CHILDREN

  1980cited by this paper
• Purification and properties of mammalian toxins from the venom of Brazilian Scorpion Tityus serrulatus Lutz and Mello.

  1977influential reference
• Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease.

  1975cited by this paper
• The dominant-lethal test: potential limitations and statistical considerations for safety evaluation.

  1973cited by this paper

• Application of a 2A-peptide system for polycistronic human IgG production in Leishmania tarentolae.

  2025cites this paper
• Characterization of Four Medically Important Toxins from Centruroides huichol Scorpion Venom and Its Neutralization by a Single Recombinant Antibody Fragment

  2022cites this paper
• Identification of cross-reactive human single-chain variable fragments against phospholipases A2 from Lachesis muta and Bothrops spp venoms.

  2020cites this paper
• Scorpion Venom: Detriments and Benefits

  2020cites this paper
• Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases

  2020cites this paper
• Pioneering Study on Rhopalurus crassicauda Scorpion Venom: Isolation and Characterization of the Major Toxin and Hyaluronidase

  2020cites this paper
• History of Envenoming Therapy and Current Perspectives

  2019cites this paper
• Ts1 from the Brazilian scorpion Tityus serrulatus: A half‐century of studies on a multifunctional beta like‐toxin

  2018cites this paper
• Pros and cons of different therapeutic antibody formats for recombinant antivenom development

  2018cites this paper
• Recent Advances in Next Generation Snakebite Antivenoms

  2018cites this paper
• Discovery of human scFvs that cross-neutralize the toxic effects of B. jararacussu and C. d. terrificus venoms.

  2018cites this paper
• Basics of Antibody Phage Display Technology

  2018cites this paper
• Venomous Arachnid Diagnostic Assays, Lessons from Past Attempts

  2018cites this paper
• SINGLE CHAIN VARIABLE FRAGMENTS OF ANTIBODIES AGAINST DIPHTHERIA TOXIN B-SUBUNIT ISOLATED FROM PHAGE DISPLAY HUMAN ANTIBODY LIBRARY Oliinyk O. S., Kaberniuk A. A., Kolibo D. V., Komisarenko S. V

  2018cites this paper
• Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1

  2017cites this paper
• Expanding biological activities of Ts19 Frag‐II toxin: Insights into IL‐17 production

  2017cites this paper
• Guiding recombinant antivenom development by omics technologies.

  2017cites this paper
• Human scFv antibodies (Afribumabs) against Africanized bee venom: Advances in melittin recognition.

  2016cites this paper
• Tityus serrulatus envenoming in non-obese diabetic mice: a risk factor for severity

  2016cites this paper
• Biotechnological Trends in Spider and Scorpion Antivenom Development

  2016cites this paper
• Evolution of alternative methodologies of scorpion antivenoms production.

  2015cites this paper
• Tityus serrulatus venom--A lethal cocktail.

  2015cites this paper
• Phage display as a novel promising antivenom therapy: a review.

  2015cites this paper
• Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential

  2014cites this paper
• Serrumab: A novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities

  2014influential citation
• Human antibody fragments specific for Bothrops jararacussu venom reduce the toxicity of other Bothrops sp. venoms

  2013cites this paper